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Mutations in CDCA7, the SNF2 family protein HELLS (LSH), or the
DNA methyltransferase DNMT3b cause immunodeficiency–centro-
meric instability–facial anomalies (ICF) syndrome. While it has
been speculated that DNA methylation defects cause this disease,
little is known about the molecular function of CDCA7 and its
functional relationship to HELLS and DNMT3b. Systematic analysis
of how the cell cycle, H3K9 methylation, and the mitotic kinase
Aurora B affect proteomic profiles of chromatin in Xenopus egg
extracts revealed that HELLS and CDCA7 form a stoichiometric
complex on chromatin, in a manner sensitive to Aurora B. Al-
though HELLS alone fails to remodel nucleosomes, we demon-
strate that the HELLS–CDCA7 complex possesses nucleosome
remodeling activity. Furthermore, CDCA7 is essential for loading
HELLS onto chromatin, and CDCA7 harboring patient ICF muta-
tions fails to recruit the complex to chromatin. Together, our study
identifies a unique bipartite nucleosome remodeling complex
where the functional remodeling activity is split between two
proteins and thus delineates the defective pathway in ICF
syndrome.
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Immunodeficiency–centromeric instability–facial anomalies (ICF)syndrome is a rare recessive autosomal disorder, causing severe
infections (1). One of the diagnostic characteristics of patients with
ICF is a unique metaphase chromosomemorphology in lymphocytes
stimulated by mitogens, where the juxtacentromeric heterochro-
matin of chromosomes 1 and 16 enriched with repetitive satellites
2 and 3, becomes stretched and fragile (2). While the molecular
basis of ICF is unknown, it is thought to be caused by defective
DNAmethylation, as the majority of patients have mutations in the
de novo DNA methyltransferase DNMT3b with hypomethylated
satellites 2 and 3 DNA (3). More recently, mutations in a tran-
scription regulator ZBTB24, a putative nucleosome remodeler
helicase, lymphoid specific (HELLS) (also known as LSH and
SMARCA6), and CDCA7 have been found to also cause reduced
satellite DNA methylation and ICF (4, 5). ZBTB24 promotes
CDCA7 transcription (6), but how HELLS and CDCA7 mutations
contribute to ICF syndrome is unknown.
HELLS is a SNF2 ATPase family protein, required for de novo
DNA methylation of repetitive elements and developmentally
programmed genes through interaction with DNMT3b (7). Among
six groups of SNF2 family proteins, HELLS belongs to a SNF2-like
subfamily, including SMARCA2/4 (BRM/BRG1), CHD3–5 (Mi-2),
CHD1/2, CHD6–9, SMARCA1/5 (SNF2L/SNF2h, ISWI) and
ALC1 (8). While the core ATPase domain of all other SNF2-like
subfamily proteins exhibit nucleosome remodeling activity (9–15),
mouse HELLS does not possess ATP-dependent nucleosome
remodeling activity in vitro (16). Furthermore, while many SNF2-
like ATPases form large multisubunit complexes, it has been sug-
gested that HELLS does not (17). However, ATPase-defective
point mutations in HELLS are unable to support de novo DNA
methylation during embryonic stem cell differentiation (18) and in
fibroblasts (19). Additionally, the Arabidopsis thaliana homolog of
HELLS, DDM1, exhibits nucleosome remodeling activity (20).
Therefore, it remains a mystery why HELLS lacks nucleosome
remodeling activity. CDCA7, containing a highly conserved 4CXXC
zinc finger domain, has been suspected to be a transcription factor
under the control of c-Myc (21–24), but little is known about its
molecular function or its relationship to HELLS and DNMT3b.
In this study, we determine how the proteomic composition of
chromatin is affected by the combinatorial effects of the cell
cycle, the heterochromatin mark H3K9me3, and the chromo-
somal passenger complex (CPC), which contains the protein ki-
nase Aurora B and plays a number of critical roles in mitotic
chromosome structure and function (25). The comparative
proteomic analysis demonstrates that most known protein com-
plex subunits associate with chromatin in equivalent amounts,
and their stoichiometry is preserved even as the absolute levels of
chromatin binding drastically change between conditions. Using
this principle, we identify a chromatin-associated complex com-
prising ICF proteins HELLS and CDCA7, and demonstrate that
HELLS–CDCA7 is a nucleosome remodeling complex, pro-
viding insight into the molecular basis of the ICF disorder.
Results
To assess the impact of the cell cycle, the heterochromatic mark
H3K9me3, and Aurora B on the proteomic composition of chro-
matin, we used Xenopus egg extracts arrested in meiotic meta-
phase II by the cytostatic factor (CSF extract). The extract was
subject to immunodepletion using control IgG (ΔMOCK) or anti-
INCENP (ΔCPC), which can effectively deplete the CPC, in-
cluding Aurora B (26). Magnetic beads coated with nucleosome
arrays reconstituted with recombinant Xenopus core histones, with
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or without H3K9me3, were added to these extracts (27, 28). Ex-
tracts were then either left in metaphase or released into in-
terphase by adding calcium before purification of beads and liquid
chromatography tandem mass spectrometry (LC-MS/MS) of
chromatin-bound proteins. This enabled a direct quantitative
comparison of chromatin proteomics under eight different condi-
tions harboring a combination of three different perturbations (cell
cycle, ±CPC, and ±H3K9me3) (Fig. 1A and Dataset S1).
The MS analysis revealed that known chromatin-associated
proteins largely exhibited the expected binding patterns across the
eight conditions. For example, all condensin and cohesin subunits
exclusively associated with chromatin in M phase and in interphase,
respectively (Fig. 1 B and C). HP1 and Suv39 exclusively interacted
with H3K9me3-chromatin in a manner sensitive to the CPC, con-
sistent with the notion that Aurora B-dependent H3S10ph disso-
ciates these chromodomain-containing proteins (Fig. S1A), while
suppression of HP1 binding to H3K9me3 nucleosomes in in-
terphase is likely due to delayed dephosphorylation of H3S10ph
(29, 30). In contrast, ATRX (and its binding partner DAXX) was
recruited to H3K9me3 in a manner independent of the CPC, con-
sistent with its H3S10ph-insensitive binding to H3K9me3 (Fig. S1B)
(31, 32). Notably, many known stoichiometric chromatin-associated
complexes, differing in abundance by orders of magnitude, includ-
ing Ku70–Ku80, MSH2–6, MCM, FACT, FANCD2–FANCI, and
astrin–kinastrin showed remarkable regularity across different con-
ditions (Fig. 1 D–F and Fig. S1 C–F).
Identification of the HELLS–CDCA7 Complex. As subunits of known
chromatin-associated complexes behaved similarly on chromatin,
we wondered whether we could identify novel chromatin-associated
complexes based on similar proteomic profiles, which have suc-
cessfully been used to identify soluble complexes (33). However, an
initial hierarchical clustering attempt failed to cluster several known
protein complex subunits, due to the presence of proteins that are
highly abundant in the extracts and likely stick nonspecifically to
chromatin beads. To circumvent this issue, we assessed relative
chromatin enrichment values by normalizing the chromatin-
associated amount by the reported protein concentrations in eggs
(34). Removing proteins whose enrichment values do not surpass
the 70th percentile at any condition, effectively reduced this con-
founding effect by nonspecific binders. Using this refined dataset,
hierarchical clustering broadly partitioned the proteins into M
phase or interphase-specific interactors. Further branching clus-
tered stoichiometric subunits of many known protein complexes
(Fig. 2A and Fig. S1 G–J).
The hierarchical clustering successfully sensed subtle differ-
ences in the proteomic profiles so that the subunits of known
protein complexes clustered together, including complexes such
as FACT and ATR/ATRIP along with ATR activators,
ETAA1 and DNA2 (35, 36), which were only subtly affected
by the experimental conditions (Fig. 2A and Fig. S1H). Re-
markably, the method successfully clustered Ku70–80 with its
F-box containing promoter of DNA binding-dependent ubiq-
uitylation, FBXL12 (Fig. S1I) (37), and RPA1–3, with known
binding partners SMARCAL1 and HELB (38–43). Interestingly,
TOPBP1, a known activator of ATR (44), clustered with its binding
partners, FANCJ (45) and RAD17 (46, 47), particularly onM phase
chromatin, but not with ATR/ATRIP, perhaps reflecting its
reported mitotic chromosome localization (48).
Encouraged by these examples of successful clustering, we
sought novel protein interactions. Among proteins that are not
previously known to form a complex, CDCA7e, the embryonic
Fig. 1. Proteomic profiling of chromatin regulation by the cell cycle, the CPC, and H3K9me3. (A) Schematic of the procedure to identify chromatin-bound
proteins in Xenopus egg extracts. Beads coated with unmodified or H3K9me3 nucleosome arrays were incubated in M phase or interphase Xenopus egg
extracts subject to CPC or mock depletion. Beads were recovered, washed, and bound proteins were analyzed by LC-MS/MS. (B–F) Abundance of condensin
(B), cohesin (C), Ku70–Ku80 (D), MSH2–6 (E), and MCM2–7 (F), identified by LC-MS/MS on the indicated chromatin beads. Abundance (arbitrary units) was
calculated by integrating LC-MS signals for each peptide, as described in Methods.
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variant of CDCA7, and HELLS clustered in our unsupervised
method (Fig. 2A and Fig. S1K) and showed strikingly similar
profiles, where equivalent amounts of these two proteins cop-
urified with chromatin beads across all eight conditions (Fig. 2B).
Quantitative Western blotting using antibodies against HELLS
and CDCA7e confirmed this stoichiometric relationship between
HELLS and CDCA7 (Fig. S2).
One of the most apparent characteristics of the HELLS–
CDCA7e behavior is its eviction from M phase chromatin in a
manner dependent on the CPC (Fig. 2 B and C). As Aurora B is
responsible for mitotic phosphorylation of H3S10 and H3S28, we
wondered whether phosphorylation of these H3 residues was
responsible for HELLS/CDCA7e eviction. Reconstituting chro-
matin beads harboring alanine or aspartate mutations at
H3S10 and H3S28 showed that HELLS is regulated by the CPC
independently of phosphorylation at these residues (Fig. 2D).
ISWI, another remodeling complex shown to be evicted from M
phase chromatin by Aurora B (49), was similarly unaffected by
H3S10 and H3S28 mutations (Fig. 2D).
As with many nucleosome remodeling complexes, including
ISWI and FACT (28), HELLS and CDCA7e are dependent on
nucleosomes for chromatin association in egg extracts (Fig. 2 E and
F). Many chromatin proteins that fail to associate with nucleosome-
free DNA in physiological cytoplasmic extract (28) possess DNA
binding activity in isolation. These include H1 (50), RCC1 (51),
topoisomerase II (28), and FACT (52). Similarly, purified HELLS–
calmodulin-binding peptide (CBP) and maltose-binding protein
(MBP)–CDCA7e also have DNA-binding activity in vitro (Fig. S3 A
and B), despite their nucleosome-dependent chromatin binding in
egg extracts. This suggests that under physiological conditions,
HELLS–CDCA7e either cannot compete with endogenous DNA
binding proteins for binding to naked DNA, or that proteins exist in
egg extract that remove HELLS–CDCA7e from DNA but not
from nucleosomes.
As the amounts of HELLS and CDCA7e on chromatin are
equivalent through a variety of conditions, we hypothesized that
they form a complex. Indeed, coimmunoprecipitation experi-
ments from chromatin-free Xenopus egg extracts showed that
HELLS and CDCA7e interact in soluble cytoplasmic extract
(Fig. 3 A and B). Furthermore, purified HELLS–CBP coimmu-
noprecipitated with MBP–CDCA7e in isolation, indicating a
direct interaction between HELLS and CDCA7e (Fig. 3C).
However, immunodepletion of either component from Xenopus
egg extract did not codeplete the other (Fig. 3D), despite their
equimolar presence in eggs (∼100 nM) (34). This suggests that
only a fraction of HELLS and CDCA7e interacts in the cyto-
plasm, consistent with a previous report that HELLS exists as a
monomer in mouse and human cells (17).
In Xenopus, many genes have an embryonic/egg specific paralog,
such as histone H1 (53), dasra A (26), and survivin (54). In agree-
ment with CDCA7e being the only detectable CDCA7 paralog in the
egg (55), we only detected peptides for CDCA7e in our proteomics
data. However, exogenously expressed somatic CDCA7 paralogs
(CDCA7 and CDCA7L) also interacted with HELLS in egg extract
(Fig. S3C), indicating that HELLS–CDCA7 interaction is conserved
among different CDCA7 paralogs.
Fig. 2. Chromatin binding of HELLS–CDCA7e is coregulated by the CPC and nucleosomes. (A) Unsupervised clustering of chromatin-associated proteins. A
heatmap of each protein’s normalized profile is displayed, with proteins enriched on a given chromatin sample colored yellow. Examples of known stoi-
chiometric chromatin-associated complexes cluster together and are indicated. Fine-grained protein complex clusters (Left) and coarse-grained cell-cycle
clusters (Right) are labeled. (B) LC-MS/MS analysis HELLS and CDCA7e copurified with unmodified or H3K9me3 nucleosome beads recovered from M phase or
interphase mock or CPC-depleted extracts. (C) Western blot analyses of HELLS and CDCA7e copurified with nucleosome beads recovered from M phase or
interphase mock or CPC-depleted extracts. Representative of n = 2 independent experiments. (D) Western blot analyses of proteins copurified with nucle-
osome beads recovered from M phase mock or CPC-depleted extracts. Nucleosomes containing wild-type H3 (SS), H3S10AS28A (AA), or H3S10DS28D (DD)
were used. (E) Western blot analyses of proteins copurified with nucleosome or DNA beads recovered from M phase or interphase H3–H4-depleted extracts.
(F) Abundance of HELLS and CDCA7e on nucleosome or DNA beads recovered fromM phase H3–H4-depleted extracts quantified by LC-MS/MS. Data from ref.
28 (originally missing CDCA7e) was reanalyzed using an mRNA reference database containing CDCA7e (34).
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CDCA7e Is Required for Chromatin Loading of HELLS. Presence of
near identical amounts of HELLS and CDCA7e on chromatin,
despite their unstable complex formation in egg extracts, can be
explained by their dependency for chromatin binding. Indeed,
while immunodepletion of HELLS from interphase extracts did
not affect chromatin binding of CDCA7e, depleting CDCA7e
greatly reduced HELLS recruitment to chromatin (Fig. 3D),
indicating that CDCA7e is required for HELLS chromatin lo-
calization, but not vice versa. Although a majority of HELLS and
CDCA7e dissociate from chromatin in M phase, MS-based
analysis on chromatin beads depleted of either CDCA7 or
HELLS indicated that binding of HELLS to chromatin also
depends on CDCA7e in M phase (Fig. 3E). Additionally, puri-
fied MBP–CDCA7e can bind DNA, nucleosome arrays con-
taining linker DNA, and mononucleosomes lacking linker DNA
in vitro (Fig. 3F and Fig. S3D). Collectively, these data suggest
that CDCA7e directly binds a nucleosome and recruits HELLS.
To test whether the CDCA7-dependent chromatin binding of
HELLS is conserved in human somatic cells, CDCA7 was de-
pleted from HeLa cells using siRNA. Quantitative Western
blotting analysis showed that CDCA7 knockdown by RNAi re-
producibly caused a decrease in chromatin-associated HELLS
(Fig. S4 A and B), suggesting that CDCA7 indeed facilitates
binding of HELLS to chromatin in somatic cells. In agreement with
our data in Xenopus extracts, HELLS and CDCA7 chromatin
binding was increased following treatment of mitotic cells with the
Aurora B inhibitor, ZM447439 (Fig. S4C). Together with the stoi-
chiometric association of CDCA7e and HELLS on chromatin that
covaries across a variety of conditions (Fig. 2 B and F), its
chromatin-independent interaction capacity (Fig. 3 A–C), and
CDCA7e/CDCA7-dependent chromatin association of HELLS
(Fig. 3 D and E and Fig. S4), we suggest that CDCA7e (and
CDCA7) and HELLS form a complex on chromatin.
CDCA7e Stimulates Nucleosome Remodeling Activity of HELLS. We
next tested whether CDCA7e is required for HELLS remodeling
activity. In agreement with a previous study (16), we saw little
remodeling with purified HELLS–CBP in a restriction enzyme
accessibility assay where productive remodeling exposes a re-
striction site within the nucleosome (Fig. 4A). However, adding
MBP–CDCA7e to HELLS–CBP resulted in robust remodeling
activity, while MBP–CDCA7e alone did not remodel the nu-
cleosome. Using native gel electrophoresis, which can distinguish
between end-positioned and center-positioned nucleosomes, we
saw that coincubation of HELLS–CBP and MBP–CDCA7e
shifts a center-positioned nucleosome to the end of the DNA
fragment, while HELLS–CBP or MBP–CDCA7e alone did not
mobilize nucleosomes (Fig. 4B). Free DNA was not generated
during the course of the remodeling, indicating that HELLS–
CDCA7e did not evict the nucleosome (Fig. S5A). Unlike
Fig. 3. CDCA7e directly recruits HELLS to chromatin. (A and B) Western blot analysis of CDCA7e (A) and HELLS (B) immunoprecipitation from M phase
Xenopus extracts. Preimmune rabbit IgG was used to control for nonspecific binding. Representative of n = 3 independent experiments. (C) Coomassie-
stained gel of purified HELLS–CBP coimmunoprecipitation with MBP–CDCA7. Purified HELLS–CBP was incubated with MBP–CDCA7e or MBP alone and
immunoisolation was performed using beads coupled with anti-MBP antibodies or control IgG. Representative of n = 2 independent experiments. (D) Western
blot analyses of proteins copurified with nucleosome beads recovered from interphase extracts mock depleted or depleted of HELLS or CDCA7e. Repre-
sentative of n = 4 independent experiments. (E) Abundance of HELLS and CDCA7e on nucleosome beads recovered from interphase or M phase extracts mock
depleted or depleted of HELLS or CDCA7e, quantified by LC-MS/MS. (F) Coomassie-stained gel of a pulldown of nucleosome or DNA beads incubated with
MBP–CDCA7e. Uncoupled beads were used to control for nonspecific binding. Representative of n = 2 independent experiments.
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SNF2h, HELLS–CDCA7e failed to generate center-positioned
nucleosomes from end-positioned nucleosomes (Fig. S5B). How-
ever, HELLS–CDCA7e can still mobilize end-positioned nucleo-
somes in a restriction enzyme accessibility assay (Fig. S5C),
suggesting that HELLS–CDCA7e does not permanently stall
at DNA ends, but continuously mobilizes end-positioned nu-
cleosomes. As previously reported (16), HELLS possesses
intrinsic DNA and nucleosome-stimulated ATPase activity
(16), which is enhanced by MBP–CDCA7e (Fig. S5 D and E),
indicating that CDCA7 may couple HELLS ATPase activity to
productive nucleosome sliding. Together, our data show that
CDCA7 is required to activate HELLS remodeling activity
and answer the longstanding question of whether HELLS is a
bona fide nucleosome remodeler.
CDCA7 Patient ICF Mutations Fail to Recruit HELLS to Chromatin.
Thus, far, all identified CDCA7 mutations in patients with ICF
map to the highly conserved zinc finger domain (Fig. 5A) (4). To
determine the molecular defect of these CDCA7 mutations, we
purified recombinant MBP–CDCA7e engineered with three
corresponding patient mutations (R232C, R232H, or R262H).
All three tested ICF mutants could interact with HELLS–GFP
generated in reticulocyte lysate (Fig. S6A), although the possi-
bility that R262H mutant has a slightly reduced affinity to
HELLS cannot be ruled out (Fig. S6B). However, CDCA7e–
R232C/H mutations displayed a strong DNA binding defect in
vitro (Fig. 5B). Accordingly, while wild-type MBP–CDCA7e
supported chromatin recruitment of HELLS in egg extracts
depleted of endogenous CDCA7e, MBP–CDCA7e–R232C/H
failed to associate with chromatin (Fig. 5C and Fig. S6C), and
to recruit HELLS. Interestingly, CDCA7e–R262H maintained
DNA-binding activity in vitro (Fig. 5B), but it failed to associate
with chromatin in egg extract (Fig. 5C). Collectively, these data
show that the primary defect of CDCA7 R232 and R262 ICF
mutations is an inability to recruit the HELLS–CDCA7 complex
to chromatin.
Because HELLS can bind DNA independently of CDCA7e in
vitro (Fig. S3B), the DNA-binding activity of CDCA7e may not
be required for nucleosome remodeling under purified condi-
tions. We therefore wondered whether CDCA7e–R232C/H DNA-
binding defective mutations could still activate HELLS remodeling
activity. Strikingly, the CDCA7e–R232H ICF mutation was capable
of activating HELLS remodeling activity under both saturating (Fig.
5D) and nonsaturating (Fig. S6 D and E) conditions, indicating that
CDCA7e can stimulate HELLS remodeling independently of its
DNA-binding activity. Additionally, the CDCA7e–R262H, which
retains DNA-binding activity in vitro, can also stimulate remodeling
activity (Fig. 5D and Fig. S6 D and E). These data suggest that in
vivo CDCA7e serves two separable functions whereby CDCA7e is
required to recruit HELLS to chromatin, and once there, CDCA7e
activates HELLS remodeling activity.
Discussion
Comparative MS-based proteomic analysis on chromatin com-
ponents in this study revealed a complex composed of HELLS
and CDCA7e, which possesses nucleosome remodeling activity.
Here, we name this complex the CDCA7–HELLS ICF-related
nucleosome remodeling complex (CHIRRC).
HELLS Requires CDCA7 to Execute Nucleosome Remodeling. Many
well-studied nucleosome remodeling complexes contain a core
ATPase subunit, which possesses intrinsic remodeling activity,
such as BRM/BRG1, Mi-2, CHD1/2, CHD6–9, SNF2L/SNF2h,
and ALC1 (9–15), though remodeling activity and directionality
can be modulated by associated proteins. These core subunits
contain an ATPase domain with flanking chromatin recognition
domains such as the tandem chromodomains in CHD1, which
couple its ATPase activity to productive nucleosome sliding. In this
study, we identify a unique remodeling complex configuration
where the nucleosome remodeling activity of the CHIRRC is split
over two polypeptides, HELLS and CDCA7. The core ATPase
subunit HELLS has no intrinsic remodeling activity, but requires
CDCA7 to couple the ATPase activity to productive remodeling.
CDCA7 has two somatic paralogs, CDCA7 and CDCA7L, which
likely activate HELLS in a similar manner. Somatic CDCA7 and
CDCA7L contain the highly conserved zinc finger domain, which
may facilitate their chromatin recruitment, while their divergent N
termini may modulate their remodeling activity, or recruit HELLS
Fig. 4. CDCA7e is an essential stimulator of HELLS nucleosome remodeling activity. (A) Restriction enzyme accessibility nucleosome remodeling assay with
HELLS–CBP and MBP–CDCA7e. The 601-positioned mononucleosomes with a PstI site engineered 15 bp into the nucleosome with 20 bp flanking DNA on each
end were incubated with the indicated remodeling proteins and PstI. Productive nucleosome sliding exposes the PstI site, resulting in cleaved DNA (arrow).
DNA was resolved on a 10% polyacrylamide gel and visualized with SYBR Gold. Representative of n = 2 independent experiments. (B) Native gel nucleosome
remodeling assay with HELLS–CBP and MBP–CDCA7e. Center-positioned mononucleosomes (same as in A) were incubated with the indicated remodeling
proteins. Reactions were stopped, resolved on a 5% polyacrylamide gel, and visualized with SYBR Gold. Sliding results in end-positioned nucleosomes, which
migrate faster. Representative of n = 2 independent experiments.
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to different genomic loci. By splitting the core remodeling protein
into two polypeptides, the CHIRRC may be differentially regulated
during development by CDCA7 paralogs. While DDM1, the Ara-
bidopsis homolog of HELLS, can remodel nucleosomes without any
additional protein in vitro (20), our observation that CDCA7mutants
defective in recruiting HELLS to chromatin can still support
remodeling activity opens a possibility that DDM1 possesses
CDCA7-like proteins that control chromatin targeting.
Fig. 5. CDCA7 ICF mutants are defective in chromatin recruitment of the HELLS–CDCA7 complex. (A) Alignment of CDCA7 zinc finger domains from the
indicated species. The 4CXXC motif is underlined, and residues with identified ICF mutations (*) are highlighted in red. (B) Coomassie-stained gel of a
pulldown of DNA beads incubated with MBP–CDCA7e harboring the indicated ICF mutations. Uncoupled beads (Bottom) were used to control for nonspecific
binding. Representative of n = 2 independent experiments. (C) Western blot analyses of proteins copurified with chromatin beads recovered from interphase
extracts mock depleted or depleted of CDCA7e. Beads coated with 19 × 601 naked DNA were chromatinized in interphase extract for 90 min before addition
of 1 μM recombinant MBP–CDCA7e harboring the indicated ICF mutations. Following an additional 60-min incubation, chromatin beads were recovered.
Representative of n = 2 independent experiments. (D) Restriction enzyme accessibility nucleosome remodeling assay with HELLS–CBP and MBP–CDCA7e with
the indicated ICF mutations. The 601-positioned mononucleosomes with a 34 and 15 bp flanking DNA on the 5′ and 3′ end, respectively, incubated with the
indicated remodeling proteins and MspI endonuclease. Productive nucleosome sliding exposes an MspI site, resulting in cleaved DNA (arrow). DNA was
resolved on a 10% polyacrylamide gel and visualized with SYBR Gold.
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Our results indicate that there are two distinct mechanisms by
which CDCA7 regulates HELLS. First, CDCA7 is required to
recruit HELLS to chromatin. Second, CDCA7 stimulates the
DNA-dependent ATPase activity and the nucleosome remodel-
ing of HELLS independently of its capacity to recruit HELLS to
chromatin (Fig. 6). Indeed, in vitro, all of the tested ICF muta-
tions of CDCA7e that affect DNA or chromatin binding still
retained remodeling activity. Although CDCA7 is critical for
recruitment of HELLS to chromatin in physiological conditions,
this functionality may be bypassed in the reconstituted system
where HELLS can interact with DNA independently of CDCA7e
(Fig. S3B). The mechanism by which HELLS interacts with DNA
in isolation in a manner independently of CDCA7e is not clear,
but it is likely that nonspecific DNA-binding activity of HELLS is
suppressed by a chaperone or by other competing DNA-binding
proteins. Whatever the mechanism, the fact that CDCA7e
without chromatin-binding capacity stimulates remodeling ac-
tivity strongly suggests that CDCA7e can activate HELLS by an
allosteric mechanism in addition to its role in chromatin re-
cruitment of HELLS.
Interestingly, a majority of the CHIRCC dissociates from chro-
matin by Aurora B in M phase, reminiscent of the mitotic regula-
tion of the ISWI remodeler (49). As the major histone targets of
Aurora B (H3S10 and H3S28) were not responsible for their dis-
sociation, uncovering the molecular determinants of this regulation
will require further investigation. We speculate that eviction of
these nucleosome remodeling proteins may modulate functionality
of mitotic chromatin regulators, such as condensin, which prefer-
entially interacts with nucleosome-free DNA (28).
CHIRCC, DNA Methylation, and ICF Syndrome. ICF syndrome has
been thought to be caused by defective de novo DNA methyl-
ation, since a majority of patients have mutations in DNMT3b
and reduced DNA methylation (3). While the role of HELLS in
DNA methylation through interaction with DNMT3b (17), and
the importance of ZBTB24 in transcriptional induction of
CDCA7 have been reported (6), how the ZBTB24–CDCA7 path-
way contributes to the HELLS–DNMT3b DNA methylation pre-
viously remained unclear. Our data provide a mechanistic
explanation of how all known ICF proteins converge on defects in
DNA methylation (Fig. 6). DNMT3b has little activity on nucleo-
somes in vitro and in vivo, which require remodeling for complete
de novo DNA methylation (56, 57). Therefore, we propose that the
CHIRRC, a bona fide nucleosome remodeler, facilitates DNMT3b
access to DNA. As HELLS deletion or ATPase mutations in mouse
lead to reduced DNA methylation at repetitive elements (58),
CDCA7 mutations in patients with ICF are likely defective in DNA
methylation due to failure in chromatin recruitment and remodeling
activity of HELLS.
Since the absence of HELLS causes ICF, but only hypomor-
phic CDCA7 mutants have been identified in CDCA7 (4), it is
conceivable that CDCA7 possesses essential roles independent
of HELLS regulation. It is also noteworthy that no DNMT3a/b
was detected on chromatin in this study or in eggs (34), sug-
gesting a role for the CHIRRC beyond DNA methylation con-
trol. However, in the context of ICF syndrome, DNMT3b,
ZBTB24, CDCA7, and HELLS likely act in the same pathway.
Further functional studies of the CHIRRC will help understand
the molecular mechanisms behind the development of ICF
phenotypes.
Methods
Xenopus Egg Extract Preparation and Immunodepletion. The Rockefeller
University Institutional Animal Care and Use Committee approved the pro-
tocol for the Xenopus laevis work, and all ethical regulations were followed.
CSF-arrested X. laevis egg crude extracts were prepared as described (59).
Extracts were kept on ice, and all extract experiments were performed at
20 °C unless specified. For experiments in interphase extract, CaCl2 was
added to 0.3 mM. To immunodeplete HELLS, CDCA7e, or the CPC in 50-μL
extract, 25 μg anti-HELLS, anti-CDCA7e, or anti-INCENP antibody was cou-
pled to 100 μL Protein A Dynabeads (Thermo Fisher Scientific). INCENP an-
tibody was crosslinked to the beads with BS3 (Thermo Fisher Scientific),
following the manufacturer’s protocol. Antibody beads were washed ex-
tensively in sperm dilution buffer (5 mM Hepes, 100 mM KCl, 150 mM su-
crose, 1 mM MgCl2, pH 8.0), split in half, and extract was depleted in two
rounds at 4 °C, each for 45 min. Beads were removed on a magnet. Mock
depletion was performed using purified preimmune rabbit IgG (Sigma-
Aldrich). Histones H3–H4 were depleted as described (28). To deplete 50-μL
extract, 130 μg anti-H4K12ac antibody was coupled to 12.5 μL rProtein A
Sepharose (GE Healthcare). Extract was rotated with beads for 60 min at 4 °C
and recovered. Depleted extract was incubated with 8.5 μL fresh rProtein A
Sepharose to recover leached antibody for 35 min at 4 °C and recovered.
Protein Purification. MBP–CDCA7–HIS was expressed in Escherichia coli at
16 °C overnight. Cells were centrifuged, resuspended in lysis buffer (1× PBS,
150 mM NaCl, 4 mM 2-mercaptoethanol, 20 mM imidazole, 0.1% Triton
X-100, 100 μM ZnSO4, 1 mM PMSF, 0.25 mg/mL lysozyme, 5 μg/mL DNaseI,
10 μg/mL leupeptin, 10 g/mL pepstatin, and 10 μg/mL chymostatin, pH 7.8),
and lysed by sonication. Lysate was centrifuged (Sorvall SS34 rotor,
14,000 rpm) for 30 min at 4 °C, and supernatant was incubated with 2 mL Ni-
NTA agarose (Qiagen) for 1 h at 4 °C. Resin was washed three times with
20 mL wash buffer (1× PBS, 150 mM NaCl, 4 mM 2-mercaptoethanol, 100 μM
ZnSO4, pH 7.8) supplemented with 20 mM imidazole, 10 mM ATP, and
2.5 mM MgCl2. Protein was eluted with wash buffer containing 400 mM
imidazole. Eluate was incubated with 5 mL amylose resin [New England
BioLabs (NEB)] for 1 h at 4 °C. Amylose resin was washed three times with
20 mL wash buffer, and MBP–CDCA7e was eluted with wash containing
20 mM maltose. Purifed MBP–CDCA7e was dialyzed in buffer (1× PBS,
150 mM NaCl, 4 mM 2-mercaptoethanol, 100 μM ZnSO4, pH 7.8) and
concentrated via spin column (Amicon).
To purify HELLS–CBP, Saccharomyces cerevisiae containing pRS306G (60),
containing HELLS–CBP were grown in YP raffinose at 30 °C to 1.3 × 107 cells
per milliliter. Protein expression was induced by adding galactose (2% final)
and incubating for 4 h. Cells were centrifuged, washed once with buffer A
(25 mM Hepes, 1 M sorbitol, pH 7.6], and once with buffer B [45 mM Hepes,
0.02% Triton X-100, 10% glycerol, 5 mM Mg (OAc)2, 0.1 M K-glutamate,
pH 7.6). Cells were resuspended in 0.5 volumes buffer B supplemented
with 1 mM DTT, 10 μg/mL leupeptin, 10 μg/mL pepstatin, and 10 μg/mL
chymostatin. Cells were frozen dropwise in liquid N2 and ground in a cryo-
genic grinding mill (SPEX). Cell powder was resuspended in buffer C (10 mM
Fig. 6. Functional mapping of proteins related to ICF syndrome. ZBTB24 stimulates transcription of CDCA7. CDCA7 associates with chromatin, recruits HELLS,
and remodels nucleosomes to allow DNMT3b-mediated DNA methylation. CDCA7 ICF mutations inhibit chromatin binding and recruitment of HELLS to
chromatin.
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Hepes, 300 mM KCl, 10 mM 2-mercaptoethanol, pH 8.0) containing 2 mM
CaCl2, and centrifuged (Sorvall SS34 rotor, 19,000 rpm) for 30 min at 4 °C.
Supernatant was incubated with 5 mL calmodulin resin for 1 h at 4 °C. Resin
was washed five times with 20 mL buffer C containing 2 mM CaCl2, and
protein was eluted with buffer C, supplemented with 10 mM EDTA. Eluate
was loaded on a heparin column (GE Healthcare), washed with buffer C, and
eluted with buffer C containing 500 mM KCl. Purified HELLS–CBP was con-
centrated by covering HELLS-containing dialysis membrane with sucrose for
1 h at 4 °C.
Histone Purification. Histones were purified as described (28). H2B, H2A, H3.2,
and H4 were individually expressed in E. coli for 4 h at 37 °C. Cells were
centrifuged, washed once with lysis buffer (50 mM Tris-Cl, 100 mM NaCl,
10 mM imidazole, 10 mM 2-mercaptoethanol, 0.25 mg/mL lysozyme, 5 μg/mL
DNaseI, 10 μg/mL leupeptin, 10 μg/mL pepstatin, and 10 μg/mL chymostatin,
pH 8.0), and resuspended in 30 mL lysis buffer. Cells were lysed by sonication
and centrifuged (Sorvall SS34 rotor, 20,000 rpm) for 15 min at 4 °C. Inclusion
bodies were rinsed with wash buffer (50 mM Tris-Cl, 100 mM NaCl, 10 mM
imidazole, 10 mM 2-mercaptoethanol, pH 8.0) and resuspended in 15 mL
wash buffer with 1% Triton X-100. Inclusion bodies were centrifuged (Sor-
vall SS34 rotor, 13,000 rpm), washed twice with wash buffer, and centri-
fuged again. Pellets were resuspended in 1 mL DMSO, diluted in 25 mL
D500 buffer (6 M guanidine HCl, 500 mM NaCl, 50 mM Tric-Cl, 5 mM
2-mercaptoethanol, 7.5 mM imidazole, pH 8.0), and rotated overnight at
room temperature. Mixture was centrifuged (Sorvall SS34 rotor, 30,000 rpm)
for 20 min at 4 °C. H2B, H3.2, and H4 were further purified by incubation
with 1.5 mL Ni-NTA agarose resin for 90 min at room temperature. Resin was
washed five times with 20 mL D500 and three times with 20 mL D1000 (6 M
guanidine HCl, 1 M NaCl, 50 mM Tric-Cl, 5 mM 2-mercaptoethanol, 7.5 mM
imidazole, pH 8.0). Proteins were eluted with 5 mL elution buffer (6 M
guanidine HCl, 1 M NaCl, 50 mM Tric-Cl, 5 mM 2-mercaptoethanol, 300 mM
imidazole, pH 7.5). H3 harboring K9 trimethylation was generated by pro-
tein semisynthesis as described (61).
H3–H4 tetramers and H2A–H2B dimers were refolded as described (28).
Each histone (45 μM) was added to 4.5 mL final volume D500. Histones were
dialyzed stepwise in dialysis buffer (20 mM Mops, 500 mM EDTA, 1 mM
EDTA, 4 mM DTT, pH 7.0) containing 10%, 5%, and 2.5% glycerol each for
4 h. Refolded histones were centrifuged, and the supernatant was incubated
with 0.02 mg/mL TEV protease overnight at 16 °C. Refolded histones were
purified by size exclusion chromatography (GE Healthcare HiLoad 16/60
Superdex 75).
Nucleosome Purification. The 19 × 601 nucleosome arrays and mono-
nucleosomes were prepared as described (28). Nineteen 601-positioning
sequences separated by 53-bp linking DNA were digested from pAS696 with
HaeII, DraI, EcoRI, and XbaI. The array was purified by PEG precipitation, and
both ends were biotinylated by Klenow (NEB) fill-in with biotin-16-dUTP
(ChemCyte). The 19 × 601 arrays were purified from free nucleotides by
Illustra Nick columns (GE Healthcare). The 19 × 601 nucleosome arrays and
mononucleosomes were prepared by gradient salt dialysis of H3–
H4 tetramers, H2A–H2B dimers onto the DNA. The quality of the array was
verified by AvaI digest, which cuts between 601 monomers, resulting in pure
mononucleosomes when resolved on a native polyacrylamide gel. Nucleo-
some arrays (900 ng) were coupled to 3 μL M-280 streptavidin Dynabeads
(Thermo Fisher Scientific) in bead coupling buffer (2.5% polyvinyl alcohol,
150 mM NaCl, 50 mM Tris-Cl, 0.25 mM EDTA, 0.05% Triton X-100, pH 8.0) at
room temperature for 3 h. When coupling naked 19 × 601 DNA to Dyna-
beads, bead-coupling buffer contained 1.5 M NaCl. To prepare mono-
nucleosomes lacking linker DNA, single-stranded 5′-biotinylated oligos of
the 601 positioning sequence containing 5 bp of 3′-flanking DNA were or-
dered (IDT Technologies) and assembled into nucleosomes by salt dialysis as
previously described.
Mass Spectrometry and Western Blots of Chromatin-Associated Proteins.
Analysis of chromatin-associated proteins was carried out as described
(28). Nucleosome beads (0.15 μL/μL extract) were incubated in Xenopus egg
extract for 2 h at 16 °C for MS experiments or 80 min at 20 °C for all other
experiments, with flicking every 20 min. The extract was diluted with
10 volumes CSF-XB (10 mM Hepes, 100 mM KCl, 1 mMMgCl2, 50 mM sucrose,
5 mM EGTA, pH 8) and recovered on a magnet for 5 min at 4 °C. Beads were
washed and recovered three times with 150 μL CSF-XB with 0.05% Triton
X-100. Beads were resuspended in SDS/PAGE buffer and boiled. The beads
were collected on a magnet and the supernatant resolved by gel electro-
phoresis. For mass spectrometry experiments, samples were run 1 cm
into the gel.
Mass Spectrometry Analysis. For MS analysis, standard trypsin digestion was
performed followed by LC-MS/MS on a Finnigan Orbitrap XL (Thermo Fisher
Scientific) mass spectrometer. MS/MS data were extracted with Proteome
Discoverer (Thermo Fisher Scientific) and queried against anmRNA-derived X.
laevis reference database (34) with Mascot (Matrix Science). This database
was crucial, since the previously used National Center for Biotechnology
Information (NCBI) database did not contain embryonic CDCA7e at the time.
Mass tolerance of 20-ppm peptide precursor and 0.5-Da peptide fragments
were used. Oxidized methionine, N-terminal acetylation, and up to three
missed cleavage sites were allowed. Proteome Discoverer (Thermo Fisher
Scientific) was used to quantify protein abundance on chromatin. LC-MS
peaks of each identified peptide were integrated, and isotope peaks for
each peptide were summed to give the total peptide area. Protein abun-
dance was calculated by averaging of the three greatest peptide signals for
each protein. Experimental reproducibility of this procedure has been
reported (28).
Unbiased clustering was performed on the top 70th percentile of
chromatin-associated proteins enriched over their extract concentration.
Clustering was performed using the HOPACH algorithm (62) using cosine
angle as the distance metric.
Coimmunoprecipitations from Xenopus Egg Extracts. For coimmunoprecipi-
tation from Xenopus egg extracts, anti-HELLS and anti-CDCA7e antibodies
(25 μg) were coupled to 100 μL Protein A Dynabeads for 1 h at room tem-
perature. Antibodies were crosslinked to the beads with BS3, following the
manufacturer’s protocol. Antibody beads were washed extensively in sperm
dilution buffer (5 mM Hepes, 100 mM KCl, 150 mM sucrose, 1 mM MgCl2,
pH 8.0). A 50-μL extract was added to the beads and incubated on ice for 1 h
with flicking every 20 min. The extract was diluted with 10 volumes CSF-XB
(100 mM KCl, 1 mM MgCl2, 50 mM sucrose, 5 mM EGTA, and 10 mM Hepes,
pH 8) and recovered on a magnet for 5 min. Beads were washed and re-
covered three times with 150 μL CSF-XB with 0.05% Triton X-100. Beads were
resuspended in SDS/PAGE buffer and boiled. Control immunoprecipitation
was performed using purified preimmune rabbit IgG (Sigma-Aldrich).
To test somatic CDCA7 and CDCA7L binding to HELLS, MYC–CDCA7, MYC–
CDCA7L, and MYC–CDCA7e, mRNA were generated with an mMESSAGE
mMACHINE SP6 kit (Life Technologies) according to the manufacturer’s in-
structions. mRNA was added to interphase Xenopus egg extract (100 μg/mL
final) and incubated for 90 min before immunoprecipitation experiment, as
described previously.
In Vitro Coimmunoprecipitations. For in vitro coimmunoprecipitation experi-
ments, 2.5 μg anti-MBP (NEB E8032) or preimmune mouse IgG (Sigma-Aldrich)
were coupled to 10 μL Protein A Dynabeads for 1 h at room temperature.
Beads were recovered on a magnet and washed extensively in sperm di-
lution buffer. Beads were resuspended in sperm dilution buffer with 0.05%
Triton X-100 and 200 nM indicated proteins. Samples were agitated for
30 min at 20 °C. Beads were recovered on a magnet and washed three times
with sperm dilution buffer with 0.05% Triton X-100. Beads were resus-
pended in SDS/PAGE buffer, resolved by gel electrophoresis, and stained
with GelCode Blue (Thermo Fisher Scientific).
To test MBP–CDCA7e ICF mutant binding to HELLS–GFP, HELLS–GFP or
GFP alone was expressed in the TnT Coupled Reticulocyte Lysate System
(Promega) according to the manufacturer’s instructions. TnT reaction was
diluted 1:5 in binding buffer (10 mM Hepes, 100 mM NaCl, 0.025% Triton
X-100, 0.25 mM TCEP, pH 7.8), containing 100 nM CDCA7e, and incubated
for 20 min at 20 °C. To each sample, 10 μL anti-MBP coated protein A beads
were added, and the sample was incubated for 20 min at 20 °C. Beads were
recovered, washed, and resolved by gel electrophoresis as before. Gel was
stained with GelCode Blue, dried, and exposed on a PhosphorImager screen.
In Vitro DNA and Nucleosome Binding. To assay CDCA7e chromatin binding in
vitro, nucleosome arrays or mononucleosomes were coupled to M280
streptavidin beads (Thermo Fisher Scientific) as described (28). For naked DNA
samples, histones were washed off in 2 M NaCl. For binding experiments,
3 μL 19 × 601 DNA or nucleosome beads were incubated in 50 μL binding
buffer (20 mM Hepes, 200 mM NaCl, 0.05% Triton X-100, 0.5 mM TCEP, pH
7.8) containing 1 μM of MBP–CDCA7e for 30 min at 20 °C. Beads were col-
lected on a magnet and washed three times with binding buffer. Beads were
resuspended in SDS/PAGE buffer, boiled, and collected on a magnet. The
supernatant was resolved by gel electrophoresis and stained with GelCode
Blue. To assay HELLS DNA binding, 3 μL DNA beads were incubated in
20 μL sperm dilution buffer with 0.05% Triton X-100 and 1 μM protein for
45 min at room temperature. Beads were collected on a magnet and washed
three times with sperm dilution buffer with 0.05% Triton X-100. Beads
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were resuspended in SDS/PAGE buffer, boiled, and collected on a magnet. The
supernatant was resolved by gel electrophoresis and stained with GelCode Blue.
Nucleosome Remodeling and ATPase Assays. To assay nucleosome remodeling
by restriction enzyme accessibility, mononucleosomes were positioned on a
601 sequence with a PstI site engineered 15 bp into the nucleosome and 20 bp
flanking DNA on each end (a gift from N. Gamarra and G. Narlikar, University
of California, San Francisco). Nucleosomes (15 nM) were added to remod-
eling buffer [6.5 mM Hepes, 2 mM ATP-Mg, 5 mM MgCl2, 70 mM KCl, 0.02%
Triton X-100, 3 units/μL PstI (NEB), pH 7.5] containing 100 nM HELLS,
CDCA7e, or SNF2h (a gift from N. Gamarra and G. Narlikar). Reactions were
incubated at 25 °C. At the indicated times, 5 μL remodeling reaction was
added to 5 μL stop buffer (20 mM Tris, 70 mM EDTA, 2% SDS, 20% glycerol,
0.2 mg/mL bromophenol blue, 3.3 mg/mL proteinase K, pH 7.5) and in-
cubated at 50 °C for 20 min. A total of 5 μL of each sample was resolved on a
10% polyacrylamide gel in 1× TBE at 150 V for 3 h and stained with SYBR
Gold for 30 min. Where indicated, a similar procedure was performed using
a mononucleosome on a 601 sequence containing 34 bp and 23 bp flanking
DNA on the 5′ and 3′ ends, respectively, and MspI restriction enzyme (NEB).
To assay mobility of end-positioned nucleosomes (Fig. S5C), mononucleosomes
were positioned on a 601 sequence containing 60 bp 3′ flanking DNA, and
the protocol was repeated using HaeIII in place of PstI.
To assay nucleosome remodeling by native gel, aforementioned center-
positioned or end-positioned mononucleosomes (20 nM) were added to
remodeling buffer (12 mM Hepes, 2 mM ATP-Mg, 3 mMMgCl2, 0.02% Triton
X-100, 70 mM KCl, 11% glycerol, pH 7.5) containing 100 nM HELLS–CBP,
MBP–CDCA7e or SNF2h (100 nM), and incubated at room temperature. At
the indicated times, 5 μL remodeling reaction was added to 5 μL stop solu-
tion (0.7 mg/mL plasmid DNA, 30 mM ADP, 20% glycerol). A total of 5 μL of
each sample was resolved on a 5% polyacrylamide gel in 0.5× TBE at 80 V for
3 h and stained with SYBR Gold.
For ATPase assays, 100 nM protein was added to 10 μL ATPase buffer
(25 mM Hepes, 60 mM KCl, 4% glycerol, 4 mM MgCl2, 1 mM cold ATP,
0.1 μCi/μL γ-33P ATP, pH 7.6) containing 40 ng/μL DNA or nucleosomes and
incubated at 16 °C. At the indicated times, 1-μL reaction was spotted on a PEI
cellulose TLC plate and dried. Plates were separated in 1.2 M KH2PO4, pH 3.8.
Plates were dried and exposed on a PhosphorImager screen.
Antibody Production and Plasmids. For antibody production, C-terminal peptides
of Xenopus H1M (CGAPVKAGKKGKKVTN), HELLS (CQGVFKVVDSTEVTVS), and
CDCA7e (CLNSLRNTKDEDSDGS) were synthesized (The Rockefeller University
Proteomics Resource Center). Peptides were coupled to keyhole limpet hemo-
cyanin according to the manufacturer’s protocol (Thermo Fisher Scientific) and
used for rabbit immunization (Cocalico Biologicals). Antibodies were affinity
purified from serum using the same peptides coupled to SulfoLink resin (Thermo
Fisher Scientific) according to the manufacturer’s protocol.
To generate H3S10ph antibodies (MAB Institute, Inc), a hybridoma clone
expressing H3S10ph-specific antibody CMA314 (3-7C4), using a synthetic peptide
ARTKQTAR(trimethyl-K) (phospho-S)TGGKAPRKQC was conjugated with keyhole
limpet hemocyanin (63). The specificity was evaluated by ELISA using various
histone H3 peptides (Fig. S7) (64). For ELISA, microtiter plates were coated with
the peptides conjugated with BSA and incubated with threefold dilutions of
hybridoma supernatant, starting from 1:100 dilution with PBS, and then with
peroxidase-conjugated anti-mouse IgG. After incubating with tetrame-
thylbenzidine, the absorbance of 405 nm was measured using a plate reader.
CMA314 reacted with H3S10ph regardless of the modification state of the
neighboring K9. To purify IgG, hybridoma cells were grown in CD Hybridoma
medium (Thermo Fisher Scientific) and the culture supernatant was passed
through a protein A column (1 mL HiTrap protein A HP Sepharose; GE
Healthcare). After eluting IgG with glycin-HCl (pH 2.8), the buffer was replaced
with PBS using an Amicon ultrafilter (50-kDa cutoff; Millipore) (63).
Codon optimized Xenopus HELLS–TEV–CBP (Thermo GeneArt Strings) was
Gibson assembled into pRS306G (60) yeast expression plasmid containing
PGK1 3′ UTR. Xenopus embryonic CDCA7e (GE EXL1051-205982802) was
Gibson assembled into pMAL (NEB). CDCA7 (GenBank accession no. BC130191),
CDCA7L (GenBank accession no. BC126014), and CDCA7e were Gibson assembled
with an N-terminal 6× MYC tag into pCS2. HELLS (NCBI Reference Sequence
accession no. NM_001092973.1) was Gibson assembled with a C-terminal GFP tag
into pCS2.
Western Blotting. Anti-Op18 rabbit antibody (a gift from R. Heald, University
of California, Berkeley, CA) was used as described (4.7 μg/mL) (65, 66). Xenopus
HELLS, CDCA7e, and H1 were detected with aforementioned rabbit anti-
bodies (1 μg/mL). Anti-human CDCA7 (15249-1-AP) was from Proteintech. Anti-
human HELLS (ab3851), anti-RPA32 (ab16855), anti-H3 (Ab1791, 1 μg/mL), and
anti-H2B (Ab1790, 1 μg/mL) antibodies were from Abcam. In Fig. S4, anti-H3
(05-499) was from EDM Millipore. Anti–phospho-Aurora B (2914, 1:200)
rabbit antibodies were from Cell Signaling. Anti-MCM7 rabbit antibody was
a gift from J. Walter (Harvard Medical School, Cambridge, MA) (1:9,000) (67).
Anti-INCENP (1 μg/mL) (26), anti-Survivin (12 μg/mL) (68), anti-Aurora B (5 μg/mL)
(66), anti-Dasra (1 μg/mL) (26), and anti–XCAP-G (28) (1 μg/ul) rabbit antibodies
were used as described. Anti-ISWI rabbit antibody was a gift from T. Hirano,
RIKEN, Wako, Saitama, Japan (49). Anti-H4K12ac antibody was a gift from
H. Kimura (69). Anti-H3T3ph was from Millipore (07-424). H3S10ph was de-
tected with a mouse monoclonal antibody (CMA314, 1 μg/mL), which allows
H3K9 mono, di-, and trimethylation and H3K9 acetylation in Fig. 2, and with a
mouse monoclonal antibody (7G1G7), which allows H3K9 mono- and dimethy-
lation, and is excluded by H3K9 trimethylation and acetylation in Fig. S4 (63).
Primary antibodies were detected with LI-COR IRDye secondary anti-
bodies and subsequently imaged and quantified on an Odyssey Infrared
Imaging System.
Protein Alignment. Protein alignment was performed with MacVector. Pro-
teins were aligned using ClustalW with an open gap penalty of 10 and an
extended gap penalty of 0.2.
Cell Cultures. HeLa cells were maintained at 37 °C in a 5% CO2 atmosphere
with 21% oxygen and grown in Dulbecco-modified MEM (DMEM) supple-
mented with 10% FBS (Atlanta Biologicals) and 100 units/mL penicillin–
streptomycin (Life Technologies). Cells were treated with 40 ng/mL nocodazole
alone or in combination with 2 μM ZM447439 for 20 h followed by col-
lection by shakeoff.
RNAi. On-TARGETplus RNAi Smartpool from Dharmacon was used for the
down-regulation of CDCA7 or nontargerting siCONTROL (D001810). Cells
were transfected with the RNAi using Lipofectamine/RNAiMAX (Thermo
Fisher Scientific) and harvested after 72 h posttransfection.
Chromatin and Whole Cell Extracts. Chromatin extracts were performed as
previously described (70). Briefly, cells were lysed into chromatin buffer
(150 mM NaCl, 50 mM Tris pH 8.0, 5 mM EDTA, 0.5% Nonidet P-40) sup-
plemented with protease inhibitors (Roche), phosphatase, Protein Phos-
phatase Inhibitor 2 (NEB), and trichostatin A HDAC inhibitor (Sigma). For the
whole cell extract, cells were lysed in 2× Laemmli buffer (71). Samples were
sonicated at 4 °C using a Bioruptor for 45 min. Concentration was de-
termined using a NanoDrop 1000 spectrophotometer (Thermo Fisher Sci-
entific) and samples were prepared for Western blotting.
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